Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2019

Okada T, Sinha S, Esposito I, Schiavon G, López-Lago MA, Su W, et al. Author Correction: The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling. Nat Cell Biol. 2019;21(4):534.

Etebari M, Navari M, Agostinelli C, Visani A, Peron C, Iqbal J, et al. Transcriptional Analysis of Lennert Lymphoma Reveals a Unique Profile and Identifies Novel Therapeutic Targets. Front Genet. 2019;10:780.

Cushing MM, Pagano MB, Jacobson J, Schwartz J, Grossman BJ, Kleinman S, et al. Pathogen reduced plasma products: a clinical practice scientific review from the AABB. Transfusion. 2019;59(9):2974-2988.

Bhardwaj P, Ikeda T, Zhou XK, Wang H, Zheng XE, Giri DD, et al. Supplemental estrogen and caloric restriction reduce obesity-induced periprostatic white adipose inflammation in mice. Carcinogenesis. 2019;40(7):914-923.

Weinberg OK, Hasserjian RP, Baraban E, Ok CY, Geyer JT, Philip JK, et al. Clinical, immunophenotypic, and genomic findings of acute undifferentiated leukemia and comparison to acute myeloid leukemia with minimal differentiation: a study from the bone marrow pathology group. Mod Pathol. 2019;32(9):1373-1385.

Mueller FB, Yang H, Lubetzky M, Verma A, Lee JR, Dadhania DM, et al. Landscape of innate immune system transcriptome and acute T cell-mediated rejection of human kidney allografts. JCI Insight. 2019;4(13).

Nuovo G, Schwartz Z, Magro C. A comparison of the detection of biomarkers in infections due to low risk versus high-risk human papillomavirus types. Ann Diagn Pathol. 2019;41:57-61.

Ouseph MM, Krigman H, He M. - An Uncommon but Noteworthy Cause of Intrauterine Fetal Demise and Acute Necrotizing Funisitis. Fetal Pediatr Pathol. 2019;38(4):352-358.

Chavda KD, Westblade LF, Satlin MJ, Hemmert AC, Castanheira M, Jenkins SG, et al. First Report of - and -Coharboring Species Isolated from a Pediatric Patient. mSphere. 2019;4(5).

Qin H, Dong Z, Wang X, Cheng WA, Wen F, Xue W, et al. CAR T cells targeting BAFF-R can overcome CD19 antigen loss in B cell malignancies. Sci Transl Med. 2019;11(511).